{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:30:34Z","timestamp":1792531834715,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78602-0","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T10:01:59Z","timestamp":1730973719000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Eosinophils mitigate intestinal fibrosis while promoting inflammation in a chronic DSS colitis model and co-culture model with fibroblasts"],"prefix":"10.1038","volume":"14","author":[{"given":"Inge","family":"Jacobs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Deleu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Jun","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Dilissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert","family":"De Hertogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobie","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Vanden Berghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Matteoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Vermeire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Breynaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Vanuytsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Verstockt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"78602_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","volume":"13","author":"HSP De Souza","year":"2016","unstructured":"De Souza, H. S. P. & Fiocchi, C. Immunopathogenesis of IBD: Current state of the art. Nat. Rev. Gastroenterol. Hepatol. 13, 13\u201327 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"78602_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1172\/JCI93557","volume":"128","author":"J Herrera","year":"2018","unstructured":"Herrera, J. et al. Extracellular matrix as a driver of progressive fibrosis. J. Clin. Invest. 128, 45\u201353 (2018).","journal-title":"J. Clin. Invest."},{"key":"78602_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.5217\/ir.2019.09148","volume":"18","author":"JH Yoo","year":"2020","unstructured":"Yoo, J. H., Holubar, S. & Rieder, F. Fibrostenotic strictures in Crohn\u2019s disease. Intest Res. 18, 379\u2013401 (2020).","journal-title":"Intest Res."},{"key":"78602_CR4","doi-asserted-by":"publisher","unstructured":"Jacobs, I. et al. Role of eosinophils in intestinal inflammation and fibrosis in inflammatory bowel disease: An overlooked villain? Front. Immunol., vol. 12 (2021). Preprint at https:\/\/doi.org\/10.3389\/fimmu.2021.754413","DOI":"10.3389\/fimmu.2021.754413"},{"key":"78602_CR5","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/j.1572-0241.2002.05687.x","volume":"97","author":"A Mir","year":"2002","unstructured":"Mir, A. et al. Elevated serum eotaxin levels in patients with inflammatory bowel disease. Am. J. Gastroenterol. 97, 1452\u20131457 (2002).","journal-title":"Am. J. Gastroenterol."},{"key":"78602_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/ibd.20018","volume":"13","author":"LC Coppi","year":"2007","unstructured":"Coppi, L. C. et al. Comparative study of eosinophil chemotaxis, adhesion, and degranulation in vitro in ulcerative colitis and Crohn\u2019s disease. Inflamm. Bowel Dis. 13, 211\u2013218 (2007).","journal-title":"Inflamm. Bowel Dis."},{"key":"78602_CR7","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1136\/gut.47.3.404","volume":"47","author":"K Geboes","year":"2000","unstructured":"Geboes, K. et al. A reproducible grading scale for histological assessment of inflammation in ulcerative colitis. Gut 47, 404\u2013409 (2000).","journal-title":"Gut"},{"key":"78602_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.3389\/fmed.2017.00093","volume":"4","author":"CN McBrien","year":"2017","unstructured":"McBrien, C. N. & Menzies-Gow, A. The biology of eosinophils and their role in asthma. Front. Med. (Lausanne) 4, 93 (2017).","journal-title":"Front. Med. (Lausanne)"},{"key":"78602_CR9","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1080\/00365521.2019.1670251","volume":"54","author":"K Amcoff","year":"2019","unstructured":"Amcoff, K. et al. Prognostic significance of faecal eosinophil granule proteins in inflammatory bowel disease. Scand. J. Gastroenterol. 54, 1237\u20131244 (2019).","journal-title":"Scand. J. Gastroenterol."},{"key":"78602_CR10","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.5114\/aoms.2013.34415","volume":"10","author":"A W\u0119drychowicz","year":"2014","unstructured":"W\u0119drychowicz, A. et al. Clinical value of serum eosinophilic cationic protein assessment in children with infflammatory bowel disease. Archives Med. Sci. 10, 1142\u20131146 (2014).","journal-title":"Archives Med. Sci."},{"key":"78602_CR11","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3390\/jcm8122025","volume":"8","author":"N Abedin","year":"2019","unstructured":"Abedin, N. et al. Fecal eosinophil cationic protein is a diagnostic and predictive biomarker in young adults with inflammatory bowel disease. J. Clin. Med. 8, 2025 (2019).","journal-title":"J. Clin. Med."},{"key":"78602_CR12","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1023\/A:1010659803912","volume":"46","author":"M Lampinen","year":"2001","unstructured":"Lampinen, M. et al. IL-5 and TNF-\u03b1 participate in recruitment of eosinophils to intestinal mucosa in ulcerative colitis. Dig. Dis. Sci. 46, 2004\u20132009 (2001).","journal-title":"Dig. Dis. Sci."},{"key":"78602_CR13","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1093\/ibd\/izaa225","volume":"27","author":"K Sugimoto","year":"2021","unstructured":"Sugimoto, K. et al. Improvement in ulcerative colitis by administration of benralizumab for comorbid refractory bronchial asthma: A novel clinical observation. Inflamm. Bowel Dis. 27, E3\u2013E4 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"78602_CR14","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1152\/ajpgi.00015.2005","volume":"289","author":"GT Furuta","year":"2005","unstructured":"Furuta, G. T. et al. Eosinophils alter colonic epithelial barrier function: Role for major basic protein. Am. J. Physiol. Gastrointest. Liver Physiol. 289, 890\u2013897 (2005).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"78602_CR15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1152\/ajprenal.00291.2018","volume":"316","author":"S Colon","year":"2019","unstructured":"Colon, S. et al. Peroxidasin and eosinophil peroxidase, but not myeloperoxidase, contribute to renal fibrosis in the murine unilateral ureteral obstruction model. Am. J. Physiol. Ren. Physiol. 316, 360\u2013371 (2019).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"78602_CR16","first-page":"2429","volume":"21","author":"JC Masterson","year":"2015","unstructured":"Masterson, J. C. et al. Eosinophils and IL-33 perpetuate chronic inflammation and fibrosis in a pediatric population with stricturing Crohn\u2019s ileitis. Inflamm. Bowel Dis. 21, 2429\u20132440 (2015).","journal-title":"Inflamm. Bowel Dis."},{"key":"78602_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/scitranslmed.aan0333","volume":"10","author":"N Takemura","year":"2018","unstructured":"Takemura, N. et al. Eosinophil depletion suppresses radiation-induced small intestinal fibrosis. Sci. Transl Med. 10, 1\u20138 (2018).","journal-title":"Sci. Transl Med."},{"key":"78602_CR18","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.4049\/jimmunol.177.7.4861","volume":"177","author":"S P\u00e9gorier","year":"2006","unstructured":"P\u00e9gorier, S., Wagner, L. A., Gleich, G. J. & Pretolani, M. Eosinophil-derived cationic proteins activate the synthesis of remodeling factors by airway epithelial cells. J. Immunol. 177, 4861\u20134869 (2006).","journal-title":"J. Immunol."},{"key":"78602_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1002\/iid3.321","volume":"8","author":"B Creyns","year":"2020","unstructured":"Creyns, B. et al. Fibrogenesis in chronic murine colitis is independent of innate lymphoid cells. Immun. Inflamm. Dis. 8, 393\u2013407 (2020).","journal-title":"Immun. Inflamm. Dis."},{"key":"78602_CR20","doi-asserted-by":"crossref","unstructured":"Yao, L. et al. Temporal control of PDGFR\u03b1 regulates the fibroblast-to-myofibroblast transition in wound healing. Cell. Rep. 40, (2022).","DOI":"10.1016\/j.celrep.2022.111192"},{"key":"78602_CR21","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1111\/j.1572-0241.1999.01223.x","volume":"94","author":"M Carlson","year":"1999","unstructured":"Carlson, M., Raab, Y., Peterson, C., H\u00e4llgren, R. & Venge, P. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. Am. J. Gastroenterol. 94, 1876\u20131883 (1999).","journal-title":"Am. J. Gastroenterol."},{"key":"78602_CR22","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1097\/00004836-200302000-00006","volume":"36","author":"ATP Carvalho","year":"2003","unstructured":"Carvalho, A. T. P. et al. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease. J. Clin. Gastroenterol. 36, 120\u2013125 (2003).","journal-title":"J. Clin. Gastroenterol."},{"key":"78602_CR23","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1097\/MPG.0b013e3182128512","volume":"52","author":"SA Woodruff","year":"2011","unstructured":"Woodruff, S. A., Masterson, J. C., Fillon, S., Robinson, Z. D. & Furuta, G. T. Role of eosinophils in inflammatory bowel and gastrointestinal diseases. J. Pediatr. Gastroenterol. Nutr. 52, 650\u2013661 (2011).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"78602_CR24","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1097\/MPG.0000000000001542","volume":"65","author":"M Roca","year":"2017","unstructured":"Roca, M. et al. Fecal calprotectin and eosinophil-derived neurotoxin in healthy children between 0 and 12 years. J. Pediatr. Gastroenterol. Nutr. 65, 394\u2013398 (2017).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"78602_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1365-2249.2004.02396.x","volume":"135","author":"U Zagai","year":"2004","unstructured":"Zagai, U., Sk\u00f6ld, C. M., Trulson, A., Venge, P. & Lundahl, J. The effect of eosinophils on collagen gel contraction and implications for tissue remodelling. Clin. Exp. Immunol. 135, 427\u2013433 (2004).","journal-title":"Clin. Exp. Immunol."},{"key":"78602_CR26","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1172\/JCI12568","volume":"107","author":"M Kolb","year":"2001","unstructured":"Kolb, M., Margetts, P. J., Anthony, D. C., Pitossi, F. & Gauldie, J. Transient expression of IL-1\u03b2 induces acute lung injury and chronic repair leading to pulmonary fibrosis. J. Clin. Invest. 107, 1529\u20131536 (2001).","journal-title":"J. Clin. Invest."},{"key":"78602_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20092121","volume":"207","author":"MS Wilson","year":"2010","unstructured":"Wilson, M. S. et al. Bleomycin and IL-1\u03b2-mediated pulmonary fibrosis is IL-17A dependent. J. Exp. Med. 207, 535\u2013552 (2010).","journal-title":"J. Exp. Med."},{"key":"78602_CR28","doi-asserted-by":"publisher","unstructured":"Borthwick, L. A. The IL-1 cytokine family and its role in inflammation and fibrosis in the lung. Seminars in Immunopathology, vol. 38 517\u2013534 (2016). Preprint at https:\/\/doi.org\/10.1007\/s00281-016-0559-z","DOI":"10.1007\/s00281-016-0559-z"},{"key":"78602_CR29","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1152\/ajpcell.00048.2001","volume":"282","author":"BC McKaig","year":"2002","unstructured":"McKaig, B. C., Hughes, K., Tighe, P. J. & Mahida, Y. R. Differential expression of TGF-beta isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am. J. Physiol. Cell. Physiol. 282, 172\u2013182 (2002).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"78602_CR30","doi-asserted-by":"crossref","unstructured":"Sun, T. et al. F I B R O S I S TGF\u03b22 and TGF\u03b23 isoforms drive fibrotic disease pathogenesis. Sci. Transl Med. 13 (2021). https:\/\/www.science.org","DOI":"10.1126\/scitranslmed.abe0407"},{"key":"78602_CR31","doi-asserted-by":"crossref","unstructured":"Liu, J. et al. Eosinophils improve cardiac function after myocardial infarction. Nat. Commun. 11, (2020).","DOI":"10.1038\/s41467-020-19297-5"},{"key":"78602_CR32","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.immuni.2022.05.014","volume":"55","author":"A Ignacio","year":"2022","unstructured":"Ignacio, A. et al. Small intestinal resident eosinophils maintain gut homeostasis following microbial colonization. Immunity 55, 1250\u20131267e12 (2022).","journal-title":"Immunity"},{"key":"78602_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000007822","volume":"62","author":"B Egger","year":"2000","unstructured":"Egger, B. et al. Characterisation of acute murine dextran sodium sulphate colitis: Cytokine profile and dose dependency. Digestion 62, 240\u2013248 (2000).","journal-title":"Digestion"},{"key":"78602_CR34","doi-asserted-by":"crossref","unstructured":"Breynaert, C. et al. Unique gene expression and MR T2 relaxometry patterns define chronic murine dextran sodium sulphate colitis as a model for connective tissue changes in human Crohn\u2019s disease. PLoS ONE 8, (2013).","DOI":"10.1371\/journal.pone.0068876"},{"key":"78602_CR35","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/mi.2013.33","volume":"7","author":"A Eken","year":"2014","unstructured":"Eken, A., Singh, A. K., Treuting, P. M. & Oukka, M. IL-23R\u2009+\u2009innate lymphoid cells induce colitis via interleukin-22-dependent mechanism. Mucosal Immunol. 7, 143\u2013154 (2014).","journal-title":"Mucosal Immunol."},{"key":"78602_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/ecco-jcc\/jjy119","volume":"13","author":"M Forkel","year":"2019","unstructured":"Forkel, M. et al. Distinct alterations in the composition of mucosal innate lymphoid cells in newly diagnosed and established Crohn\u2019s disease and ulcerative colitis. J. Crohns Colitis 13, 67\u201378 (2019).","journal-title":"J. Crohns Colitis"},{"key":"78602_CR37","doi-asserted-by":"crossref","unstructured":"Cicchi, R. & Pavone, F. S. Probing Collagen Organization: Practical Guide for Second-Harmonic Generation (SHG) Imaging, vol. 1627 (Springer New York, 2017).","DOI":"10.1007\/978-1-4939-7113-8_27"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78602-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78602-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78602-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T10:07:03Z","timestamp":1730974023000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78602-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78602"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78602-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"19 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"TV has received research support, lecture and consultancy fees from Takeda. BV reports research support from AbbVie, Biora Therapeutics, Landos, Pfizer, Sossei Heptares and Takeda; speaker\u2019s fees from Abbvie, Biogen, Bristol Myers Squibb, Celltrion, Chiesi Falk, Ferring, Galapagos, Janssen, Lily, MSD, Pfizer, R-Biopharm, Sandoz, Takeda, Tillots Pharma, Truvion and Viatris; consultancy fees from Abbvie, Almentiv, Applied Strategic, Atheneum, BenevolentAI, Biora Therapeutics, Bristol Myers Squibb, Galapagos, Guidepoint, Landos, Lily, Mylan, Inotrem, Ipsos, Janssen, Prifer, Progenity, Sandoz, Santa Ana Bio, Sosei Heptares, Takeda, Tillots Pharma and Viatris. SV receives financial support for research from AbbVie, J&J, Pfizer, Takeda and Galapagos; receives speakers\u2019 and consultancy fees from AbbVie, AbolerIS Pharma, AgomAb, Alimentiv, Arena Pharmaceuticals, AstraZeneca, Avaxia, BMS, Boehringer Ingelheim, Celgene, CVasThera, Cytoki Pharma, Dr Falk Pharma, Ferring, Galapagos, Genentech-Roche, Gilead, GSK, Hospira, Imidomics, Janssen, J&J, Lilly, Materia Prima, MiroBio, Morphic, MrMHealth, Mundipharma, MSD, Pfizer, Prodigest, Progenity, Prometheus, Robarts Clinical Trials, Second Genome, Shire, Surrozen, Takeda, Theravance, Tillots Pharma AG, Zealand Pharma. GDH receives fees for his activities as central pathology reader from Centocor and receives speakers\u2019 fees from Janssen. CB has received research fees from Ablynx. All other authors do not have any interest to disclose. Other authors to not have any interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27133"}}